Grégory Lazarian

Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study

Anne Quinquenel, Luc‐Matthieu Fornecker, Rémi Letestu et al. · Blood · 2019 · 129 citations · Full text

Life Sciences, Genetics, Hematology +10

A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation

Grégory Lazarian, Shanye Yin, Elisa ten Hacken et al. · Cancer Cell · 2021 · 60 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Inhibitors of <scp>BCR</scp> signalling interrupt the survival signal mediated by the micro‐environment in mantle cell lymphoma

Sophie Bernard, Damien Danglade, Laura Gardano et al. · International Journal of Cancer · 2014 · 52 citations · Full text

Medicine, Cancer Biology, Oncology +17

Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis

Julien Broséus, Sébastien Hergalant, J. Vogt et al. · Nature Communications · 2023 · 35 citations · Full text

Medicine, Hematology, Oncology +17

TP53 mutations are early events in chronic lymphocytic leukemia disease progression and precede evolution to complex karyotypes

Grégory Lazarian, Eugen Tausch, Virginie Éclache et al. · International Journal of Cancer · 2016 · 27 citations · Full text

Life Sciences, Genetics, Hematology +17